Ardsley Advisory Partners LP Tyme Technologies, Inc. Transaction History

Ardsley Advisory Partners LP

  • $564 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$2.01 - $4.21 $1.81 Million - $3.8 Million
-902,500 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$2.18 - $3.44 $285,580 - $450,640
-131,000 Reduced 12.68%
902,500 $2.51 Million
Q2 2018

Aug 14, 2018
BUY
$2.05 - $4.09 $201,924 - $402,865
98,500 Added 10.53%
1,033,500 $3.27 Million
Q1 2018

May 15, 2018
BUY
$2.12 - $7.0 $1.98 Million - $6.55 Million
935,000 New
935,000 $2.09 Million

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Ardsley Advisory Partners LP Portfolio

Follow Ardsley Advisory Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Ardsley Advisory Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email